Sunday 11 October 2026 Export all LLY data to Excel Powerpack

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,179.27 9.67 +0.83%
Market cap
$1.10T
P/E
39.6×
Fwd P/E
33.1×
Dividend yield
0.57%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
9 8 7 8

+8 more TTM periods

ROE
102.29% 107.46% 101.16% 96.47%
ROA
21.97% 24.54% 21.59% 19.33%
ROIC
26.33% 30.18% 26.61% 25.82%
Return on Tangible Assets
57.79% 56.50% 45.79% 41.61%
Average Days of Receivables
107.56 106.99 112.87 119.52
Free Cash Flow per Share
20.38 13.22 10.00 10.34
Free Cash Flow
18,190.00 11,823.00 8,972.00 9,271.80
Capital Expenditures
(9,893.00) (8,657.00) (7,841.00) (6,790.50)
Other line items
Cash ROIC
18.61% 15.59% 11.76% 12.42%
Accounts Receivable Turnover
3.92 4.11 3.90 3.77
Accounts Payable Turnover
2.60 2.93 2.57 2.82
Inventory Turnover
0.95 1.04 1.04 1.03
Average Days of Payables
168.70 147.98 177.65 154.26
Days of Inventory on Hand
463.51 427.53 453.91 440.85
Tax Rate
(0.20) (0.19) (0.20) (0.18)
Research and Development Expense of Revenue
18.32% 19.53% 20.46% 21.13%
Selling, General and Administrative Expense of Revenue
15.36% 16.00% 17.02% 17.48%
Share Based Compensation of Revenue
0.81% 0.88% 0.96% 1.06%
Interest Coverage
83.46 — — —
Operating CF/Net income
1.05 0.81 0.81 0.87
Depreciation/Fixed assets
0.07 0.08 0.08 0.09
Capex/Depreciation
(4.71) (4.24) (3.93) (3.58)
Revenue per Share
89.27 80.77 72.64 66.25
Operating CF per Share
31.47 22.90 18.74 17.91
Capex per Share
(11.09) (9.68) (8.74) (7.57)
Capex to Sales
0.12 0.12 0.12 0.11

Fold the line items

Columns are period end dates